Abstract:Purpose/Objective(s) Mouse models of HNC have played an essential role in elucidating mechanisms driving tumor development and progression. However, the generation of new mouse models are extremely costly, laborious and time consuming, and are limited to the study of a few, and often “popular,” gene targets that do not fully recapitulate the intertumoral heterogeneity of HNCs. Using a novel preclinical model developed in our lab that involves the in vivo introduction of human-relevant HNC mutations by CRISPR-mediated gene editing, we aim to functionally interrogate and reveal molecular pathways and mechanisms driving tumor initiation and progression, and to test the highly intriguing, but as yet unproven, hypothesis that HNC initiation is driven by the acquisition and accumulation of mutations in somatic tissue stem cells and their progeny, a process of mutagenesis that may be influenced by sex and accelerated following carcinogen exposure. Materials/Methods Our data shows effective AAV transduction and targeted mutagenesis of multiple stem cell lineages (epithelial stem cells, mesenchymal stromal cells, and muscle stem cells) by numerous AAV serotypes after local AAV injection into the tongue, oral epithelium, pharynx/esophagus, and neck. Delivery of a custom AAV-CRISPR-library (10 sgRNAs/gene), targeting the 20 most frequently mutated genes in human HNCs, into male and female mice (n=32) conditionally expressing Cas9 in a lineage-selective manner, produced morphologically and anatomically distinct tumors that recapitulate the genetic heterogeneity and sex-variant emergence of human HNCs. Results Individual tumors show distinct combinations of missense (M), nonsense (N) and silent mutations in targeted genes that also are mutated in human HNCs (sample type [tumor vs PAT]: p<0.0001; mutation type [missense vs nonsense vs silent]: p<0.0001; anatomic location: p<0.0001) Molecular sequencing analysis from AAV-CRISPR-HNC tumors (n=29) reveal striking genetic diversity and high mutational burden that is reminiscent of human HNCs. Sequencing analysis from paired adjacent tissue (PAT; n=29) provides evidence of an intermediate precancerous state and field cancerization and points to a subset of the genetic targets in our custom library as particularly consequential for stem cell transformation in this model (gene, p<0.001; mutation type, p<0.001; anatomic location, p<0.001). Frameshift insertions/ deletions accounted for the majority of INDELS observed (>50%; p<0.0001), and further supports the use of our platform to introduce loss of function mutations in HNC tumors. Conclusion Taken together, our data suggests for the first time that somatic stem cells can serve as cells-of-origin for multiple, different HNC subtypes, and that HNCs may represent clonal diseases. Future applications of this innovative and translationally-oriented system will help to nominate new therapeutic targets and create a springboard for efforts to prevent and treat HNC.

An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation

Abstract. The lack of reliable animal models to assess the safety and efficacy of drugs and to explore the underlying molecular mechanisms is one of the most severe impedi- ments in head and neck squamous cell carcinoma (HNSCC)

Mouse Models for Head and Neck Squamous Cell Carcinoma

Novel Syngeneic Animal Model of Tobacco-Associated Oral Cancer Reveals the Activity of in Situ Anti-Ctla-4

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

A Novel Immunocompetent Preclinical Mouse Model to Uncover Oncogenic Initiators of Head and Neck Cancer

Mouse Models for Human Head and Neck Squamous Cell Carcinomas

Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma

A novel orthotopic mouse model of head and neck cancer and lymph node metastasis

Establishment of a Cervical Cancer Model Via Inoculating SiHa Cells into Humanized Severe Combined Immunodeficient Mice.

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data

Establishment of NOD/SCID Mouse Models of Human Hepatocellular Carcinoma Via Subcutaneous Transplantation of Histologically Intact Tumor Tissue.

Establishment of a visualized mouse orthotopic model of nasopharyngeal carcinoma.

Syngeneic Murine Models with Distinct Immune Microenvironments Represent Subsets of Human Intrahepatic Cholangiocarcinoma

Establishment of a DEN-induced mouse model of esophageal squamous cell carcinoma metastasis

Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules

Combination Radiation and Gene Therapy for Head and Neck Squamous Cell Carcinoma in the Murine Model

Quantitative Systems Pharmacology Modeling of PBMC-Humanized Mouse to Facilitate Preclinical Immuno-oncology Drug Development

Comparative Analysis of Tumor-Infiltrating Lymphocytes in a Syngeneic Mouse Model of Oral Cancer

Abstract 1657: Syngeneic tumor development, treatment responses and immune infiltrate in subcutaneous and orthotopic mouse models